Skip to search formSkip to main contentSkip to account menu

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Known as: PLCO 
The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, or PLCO Trial, is a large-scale study to determine if certain tests will reduce… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
To examine mortality and morbidity after prostate biopsy in the intervention arm of the Prostate, Lung, Colorectal and Ovarian… 
Review
2013
Review
2013
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.
The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial is a large-scale research effort conducted by the… 
Review
2013
Review
2013
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
BACKGROUND Lung cancer is by far the major cause of cancer deaths largely because in the majority of patients it is at an… 
Highly Cited
2013
Highly Cited
2013
Circulating Adipokine Levels and Endometrial Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Background: Circulating adipokine levels may be associated with endometrial cancer risk, yet few studies have evaluated these… 
Highly Cited
2011
Highly Cited
2011
Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic… 
2009
2009
Recruitment methods employed in the prostate, lung, colorectal, and ovarian cancer screening trial
Background The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is a US National Cancer Institute (NCI… 
Highly Cited
2008
Highly Cited
2008
Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
ObjectiveA history of diabetes has been fairly consistently related to a reduced prostate cancer risk, but previous… 
Highly Cited
2008
Highly Cited
2008
Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Highly Cited
2007
Highly Cited
2007
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.
Volunteers for prevention or screening trials are generally healthier and have lower mortality than the general population. The… 
Highly Cited
2005
Highly Cited
2005
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)